Intracerebroventricular administration of taurine impairs learning and memory in rats

Nutritional Neuroscience

Volumn 15, Issue 2, 2012, Pages 70-77

  Ito, Koichi ^a   Arko, Matevž ^a   Kawaguchi, Tomohiro ^a   Kikusui, Takefumi ^b   Kuwahara, Masayoshi ^a   Tsubone, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b AZABU UNIVERSITY   (Japan)

Author keywords

Intracerebroventricular administration; Learning; Memory; Taurine; Water maze

Indexed keywords

TAURINE;

ANALYTICAL PARAMETERS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; NONHUMAN; OUTCOME ASSESSMENT; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; RAT; SWIMMING;

ANIMALS; INFUSIONS, INTRAVENTRICULAR; INJECTIONS, INTRAPERITONEAL; MALE; MAZE LEARNING; MEMORY; RATS; RATS, WISTAR; TAURINE;

RATTUS;

EID: 84858779036     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830511Y.0000000036     Document Type: Article

References (43)

1. Franconi F, Martini F, Stendardi I, Matucci R, Zilletti L, Giotti A. Effect of taurine on calcium levels and contractility in guinea-pig ventricular strips. Biochem Pharmacol 1982;31:3181-5.
2. Kramer JH, Chovan JP, Schaffer SW. Effect of taurine on calcium paradox and ischemic heart failure. Am J Physiol 1981;240:H238-46.
3. Crosignani A, Setchell KD, Invernizzi P, Larghi A, Rodrigues CM, Podda M. Clinical pharmacokinetics of therapeutic bile acids. Clin Pharmacokinet 1996;30:333-58.
4. Curtis DR, Johnston GA. Amino acid transmitters in the mam-malian central nervous system. Ergeb Physiol 1974;69:97-188.
5. Kuriyama K. Taurine as a neuromodulator. Fed Proc 1980;39: 2680-4.
6. Jiang Z, Krnjevic K, Wang F, Ye JH. Taurine activates strych-nine-sensitive glycine receptors in neurons freshly isolated from nucleus accumbens of young rats. J Neurophysiol 2004;91: 248-57.
7. Wu J, Kohno T, Georgiev SK, Ikoma M, Ishii H, Petrenko AB, et al. Taurine activates glycine and gamma-aminobutyric acid A receptors in rat substantia gelatinosa neurons. Neuroreport 2008; 19:333-7.
8. Galarreta M, Bustamante J, Martin del Rio R, Solis JM. Taurine induces a long-lasting increase of synaptic efficacy and axon excitability in the hippocampus. J Neurosci 1996;16: 92-102.
9. Del Olmo N, Galarreta M, Bustamante J, Martin del Rio R, Solis JM. Taurine-induced synaptic potentiation: role of calcium and interaction with LTP. Neuropharmacology 2000;39:40-54.
10. Del Olmo N, Handler A, Alvarez L, Bustamante J, Martin del Rio R, Solis JM. Taurine-induced synaptic potentiation and the late phase of long-term potentiation are related mechanistically. Neuropharmacology 2003;44:26-39.
11. Suarez LM, Solis JM. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons. Eur J Neurosci 2006;24:405-18.
12. Ito K, Contractor A, Swanson GT. Attenuated plasticity of post-synaptic kainate receptors in hippocampal CA3 pyramidal neurons. J Neurosci 2004;24:6228-36.
13. Sergeeva OA, Chepkova AN, Doreulee N, Eriksson KS, Poelchen W, Monnighoff I, et al. Taurine-induced long-lasting enhancement of synaptic transmission in mice: role of transporters. J Physiol 2003;550:911-9.
14. Bichler A, Swenson A, Harris MA. A combination of caffeine and taurine has no effect on short term memory but induces changes in heart rate and mean arterial blood pressure. Amino Acids 2006;31:471-6.
15. Sakata Y, Chida R, Ishige K, Edagawa Y, Tadano T, Ito Y. Effect of a nutritive-tonic drink on scopolamine-induced memory impairment in mice. Biol Pharm Bull 2005;28:1886-91.
16. Sakata Y, Ishige K, Ohtakara T, Ito Y. Natural drug extracts for a nutritive-tonic drink, promotes the induction of long-term potentiation in rat hippocampal dentate gyrus in vivo. Neurosci Res 2006;55:327-33.
17. Ito K, Arko M, Kawaguchi T, Kuwahara M, Tsubone H. The effect of subacute supplementation of taurine on spatial learning and memory. Exp Anim 2009;58:175-80.
18. El Idrissi A. Taurine improves learning and retention in aged mice. Neurosci Lett 2008;436:19-22.
19. Sanberg PR, Fibiger HC. Impaired acquisition and retention of a passive avoidance response after chronic ingestion of taurine. Psychopharmacology (Berl) 1979;62:97-9.
20. Malcangio M, Bartolini A, Ghelardini C, Bennardini F, Malmberg-Aiello P, Franconi F, et al. Effect of ICV taurine on the impairment of learning, convulsions and death caused by hypoxia. Psychopharmacology (Berl) 1989;98:316-20.
21. Li F, Obrosova IG, Abatan O, Tian D, Larkin D, Stuenkel EL, et al. Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats. Am J Physiol Endocrinol Metab 2005;288:E29-36.
22. Serrano MI, Goicoechea C, Serrano JS, Serrano-Martino MC, Sanchez E, Martin MI. Age-related changes in the antinociception induced by taurine in mice. Pharmacol Biochem Behav 2002;73:863-7.
23. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984; 11:47-60.
24. Kikusui T, Takeuchi Y, Mori Y. Involvement of corticotropin-releasing factor in the retrieval process of fear-conditioned ultra-sonic vocalization in rats. Physiol Behav 2000;71:323-8.
25. Louzada PR, Paula Lima AC, Mendonca-Silva DL, Noel F, De Mello FG, Ferreira ST. Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders. FASEB J 2004;18: 511-8.
26. Suarez LM, Suarez F, Del Olmo N, Ruiz M, Gonzalez-Escalada JR, Solis JM. Presynaptic NMDA autoreceptors facilitate axon excitability: a new molecular target for the anticonvulsant gabapentin. Eur J Neurosci 2005;21:197-209.
27. Stapleton PP, Mahon TM, Nowlan P, Bloomfield FJ. Effects of in-vivo administration of taurine and HEPES on the inflammatory response in rats. J Pharm Pharmacol 1994;46:745-50.
28. Murphy MT, Lipton JM, Loughran P, Giesecke AH, Jr. Postanesthetic shivering in primates: inhibition by peripheral heating and by taurine. Anesthesiology 1985;63:161-5.
29. Inoue A, Takahashi H, Lee LC, Sasaki S, Takeda K, Yoshimura M, et al. Hypotensive responses to centrally administered taurine in DOCA-salt hypertensive and spontaneously hypertensive rats. Jpn Circ J 1986;50:1215-23.
30. Huxtable R, Bressler R. Taurine and isethionic acid: distribution and interconversion in the rat. J Nutr 1972;102:805-14.
31. Lee NY, Kang YS. The brain-to-blood efflux transport of taurine and changes in the blood-brain barrier transport system by tumor necrosis factor-alpha. Brain Res 2004;1023: 141-7.
32. Chepkova AN, Sergeeva OA, Haas HL. Taurine rescues hippocampal long-term potentiation from ammonia-induced impairment. Neurobiol Dis 2006;23:512-21.
33. Rivas-Arancibia S, Dorado-Martinez C, Borgonio-Perez G, Hiriart-Urdanivia M, Verdugo-Diaz L, Duran-Vazquez A, et al. Effects of taurine on ozone-induced memory deficits and lipid peroxidation levels in brains of young, mature, and old rats. Environ Res 2000;82:7-17.
34. Zhu DM, Wang M, She JQ, Yu K, Ruan DY. Protection by a taurine supplemented diet from lead-induced deficits of long-term potentiation/depotentiation in dentate gyrus of rats in vivo. Neuroscience 2005;134:215-24.
35. Vohra BP, Hui X. Improvement of impaired memory in mice by taurine. Neural Plast 2000;7:245-59.
36. Matsuda T, Takuma K, Kishida Y, Azuma J, Baba A. Protective effect of taurine against reperfusion injury in cultured rat astrocytes. Adv Exp Med Biol 1996;403:491-7.
37. Kontro P, Oja SS. Taurine and GABA release from mouse cerebral cortex slices: potassium stimulation releases more taurine than GABA from developing brain. Brain Res 1987;465:277-91.
38. Schneider U, Wohlfarth K, Schulze-Bonhage A, Haacker T, Muller-Vahl KR, Zedler M, et al. Effects of acamprosate on memory in healthy young subjects. J Stud Alcohol 1999;60: 172-5.
39. Del Olmo N, Suarez LM, Orensanz LM, Suarez F, Bustamante J, Duarte JM, et al. Role of taurine uptake on the induction of long-term synaptic potentiation. Eur J Neurosci 2004;19: 1875-86.
40. Zhang CG, Kim SJ. Taurine induces anti-anxiety by activating strychnine-sensitive glycine receptor in vivo. Ann Nutr Metab 2007;51:379-86.
41. Whirley BK, Einat H. Taurine trials in animal models offer no support for anxiolytic, antidepressant or stimulant effects. Isr J Psychiatry Relat Sci 2008;45:11-8.
42. Minato A, Hirose S, Ogiso T, Uda K, Takigawa Y. Distribution of radioactivity after administration of taurine-35S in rats. Chem Pharm Bull (Tokyo) 1969;17:1498-504.
43. Lallemand F, De Witte P. Taurine concentration in the brain and in the plasma following intraperitoneal injections. Amino Acids 2004;26:111-6.